Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran

Clinical trial NCT02331602 · UNKNOWN

Trial details

NCT number: NCT02331602
Sponsor: Yokohama City University Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2013-07-01
Primary completion: 2015-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.